期刊文献+

乳腺癌骨转移动物模型的构建 被引量:5

An animal model of breast carcinoma bone metastasis in vivo
下载PDF
导出
摘要 目的:建立乳腺癌骨转移动物模型。方法:40只4周~6周龄雌性裸鼠随机分为5组,每组8只,用浓度分别为1×105/ml、1×106/ml、5×106/ml、1×107/ml、5×107/ml的MDA-MB-231细胞悬液0.1ml行左心室注射。观察裸鼠左心室注射致死情况及存活裸鼠49 d后骨转移发生情况。结果:左心室穿刺注射总致死率为32.50%(13/40);各组左心室穿刺注射致死率分别为1/8、1/8、1/8、3/8、7/8,组间比较差异有统计学意义(P=0.004)。全组骨转移发生率为48.15%(13/27);各组骨转移发生率分别为0/7、3/7、5/7、4/5、1/1,各组骨转移发生情况差异有统计学意义(P=0.014)。结论:经裸鼠左心室穿刺注射肿瘤细胞成功建立了乳腺癌骨转移动物模型,肿瘤细胞浓度为5×106/ml时是经裸鼠左心室注射建立乳腺癌骨转移动物模型的适宜浓度。 Objective : To establish an animal model of human breast cancer metastasis to bone in vivo. Methods: Forty female nude mice aged 4 -6 weeks were divided equally into 5 groups, and injected with MDA-MB-231 cells suspended in 0.1 ml PBS at the concentrations of 1 × 10^5 ( group 1 ), 1 × 10^6 ( group 2), 5 × 10^6( group 3), 1 × 10^7( group 4) and 5 × 10^7/ml (group 5) into the left heart ventricles. Deaths following the injection were recorded, and the mice that survived 49 days after the injection were subjected to pathological examination to determine bone metastasis. Results : Thirteen (32.50%) of 40 mice died after the injection, 1/8, 1/8, 1/8, 3/8 and 7/8 respectively in the 5 groups, with statistically significant differences in mortality (P = 0.004). The total bone metastasis rate was 48.15% (13/27), 0/7, 3/7, 5/7, 4/5 and 1/1 respectively in the 5 groups, with significant differences in between (P = 0. 014). Conclusion : We successfully established an animal model of breast cancer bone metastasis in vivo by injecting MDA-MB-231 cells at different concentrations into the left heart ventricles of nude mice, and found that the suitable concentration was 5 × 10^6 MDA-MB-231 cells suspended in 0.1 ml PBS.
出处 《医学研究生学报》 CAS 2008年第11期1143-1145,I0016,共4页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30700814) 第三军医大学2006年度中青年科研基金资助项目
关键词 乳腺癌 骨转移 动物模型 左心室注射 MDA-MB-231细胞株 Breast cancer Bone metastasis Animal model Injection into the left cardiac ventri- cle MDA-MB-231 cell line
  • 相关文献

参考文献7

  • 1Cicek M, Oursler MJ. Breast cancer bone metastasis and current small therapeutics [ J ]. Cancer Metastasis Rev, 2006, 25 ( 4 ) : 635 -644. 被引量:1
  • 2朱振新,顾军,于泽平.乳腺癌新辅助化疗的若干进展[J].医学研究生学报,2008,21(2):203-206. 被引量:24
  • 3王少华,于泽平,李宁,黎介寿.乳腺癌新辅助化疗的现状和展望[J].医学研究生学报,2008,21(9):986-989. 被引量:18
  • 4Thomas JR, Sarah HT, Bruce EL, et al. Animal Models of Bone Metastasis [ J ]. Cancer, 2003,97 ( S3 ) : 748-757. 被引量:1
  • 5Kang Y, Siegel PM, Shu W, et al. A muhigenic program mediating breast cancer metastasis to bone [ J ]. Cancer Cell, 2003, 3 (6) : 537-549. 被引量:1
  • 6Guise TA, Yin JJ, Thomas R J, et al. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo[ J]. Bone, 2002,30(5) : 670-676. 被引量:1
  • 7Shimo T, Kubota S, Yoshioka N, et al. Pathogenic role of connective tissue growth factor ( CTGF/CCN2 ) in osteolytic metastasis of breast cancer[J]. J Bone Miner Res, 2006, 21 (7) : 1045- 1059. 被引量:1

二级参考文献50

共引文献35

同被引文献38

  • 1郑雅娟,邓甬川.乳腺癌预后的分子标志物研究进展[J].国外医学(肿瘤学分册),2005,32(4):286-288. 被引量:8
  • 2蒋爱梅,郉海霞,普萍,马黎明,董坚.三种乳腺癌骨转移模型复制方法比较研究[J].昆明医学院学报,2007,28(1):14-18. 被引量:5
  • 3黄立中,莫新民.骨转移瘤的中医病机认识与治疗[J].湖南中医药导报,1997,3(2):5-6. 被引量:13
  • 4Fan S,Wang J,Yuan R,et al.BRCA1 inhibition of estrogen receptor signaling in transfected cellsScience,1999. 被引量:2
  • 5Troudi W,Uhrhammer N,Ben Romdhane K,et al.Immunolocal-ization of BRCA1 protein in tumor breast tissue:prescreening ofBRCA1 mutation in Tunisian patients with hereditary breast cancerEuropean Journal of Histochemistry,2007. 被引量:1
  • 6Rakha EA,El-Sheikh SE,Kandil MA,et al.Expression of BRCA1protein in breast cancer and its prognostic significanceHuman Pathology,2008. 被引量:1
  • 7M Robson,T Gilewski,B Haas,D Levin,P Borgen,P Rajan,Y Hirschaut,P Pressman,PP Rosen,ML Lesser,L Norton,K Offit.BRCA-associated breast cancer in young womenJournal of Clinical Oncology,1998. 被引量:1
  • 8J Taylor,M Lymboura,PE Pace.An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancersInternational Journal of Cancer,1998. 被引量:1
  • 9TK MacLachlan,BC Dash,DT Dicker,WS El-Deiry.Repression of BRCA1 through a feedback loop involving p53Journal of Biological Chemistry,2000. 被引量:1
  • 10Lidereau,R,Eisinger,F,Champeme,M-H,Nogues,C,Bieche,I,Birnbaum,D.Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancerCancer Research,2000. 被引量:1

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部